| Style | Citing Format |
|---|---|
| MLA | Karami H, et al.. "Exploring the Association Between the Lineages of Human Papillomavirus Type 16 and Viral Physical Status in the Development of Cervical Cancer in Iran." Scientific Reports, vol. 15, no. 1, 2025, pp. -. |
| APA | Karami H, Soleimanijelodar R, Khezeli Z, Shoja Z, Arashkia A, Varmazyar S, Jalilvand S (2025). Exploring the Association Between the Lineages of Human Papillomavirus Type 16 and Viral Physical Status in the Development of Cervical Cancer in Iran. Scientific Reports, 15(1), -. |
| Chicago | Karami H, Soleimanijelodar R, Khezeli Z, Shoja Z, Arashkia A, Varmazyar S, Jalilvand S. "Exploring the Association Between the Lineages of Human Papillomavirus Type 16 and Viral Physical Status in the Development of Cervical Cancer in Iran." Scientific Reports 15, no. 1 (2025): -. |
| Harvard | Karami H et al. (2025) 'Exploring the Association Between the Lineages of Human Papillomavirus Type 16 and Viral Physical Status in the Development of Cervical Cancer in Iran', Scientific Reports, 15(1), pp. -. |
| Vancouver | Karami H, Soleimanijelodar R, Khezeli Z, Shoja Z, Arashkia A, Varmazyar S, et al.. Exploring the Association Between the Lineages of Human Papillomavirus Type 16 and Viral Physical Status in the Development of Cervical Cancer in Iran. Scientific Reports. 2025;15(1):-. |
| BibTex | @article{ author = {Karami H and Soleimanijelodar R and Khezeli Z and Shoja Z and Arashkia A and Varmazyar S and Jalilvand S}, title = {Exploring the Association Between the Lineages of Human Papillomavirus Type 16 and Viral Physical Status in the Development of Cervical Cancer in Iran}, journal = {Scientific Reports}, volume = {15}, number = {1}, pages = {-}, year = {2025} } |
| RIS | TY - JOUR AU - Karami H AU - Soleimanijelodar R AU - Khezeli Z AU - Shoja Z AU - Arashkia A AU - Varmazyar S AU - Jalilvand S TI - Exploring the Association Between the Lineages of Human Papillomavirus Type 16 and Viral Physical Status in the Development of Cervical Cancer in Iran JO - Scientific Reports VL - 15 IS - 1 SP - EP - PY - 2025 ER - |